Search Results 1171-1180 of 16994 for monoclonal antibody
Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...
— All too often, patients with high levels of antibodies face major challenges getting a transplant. These highly sensitized patients have a much higher risk of ...
Monoclonal antibodies: at least 3 half-lives of the antibody after the last dose; Radiation therapy (RT): patients must have had their last fraction of ...
Previous in vivo exposure to monoclonal antibodies for biological therapy in the 6 weeks before enrollment. Planned administration of growth factors or ...
Learn about this cancer that forms from white blood cells called plasma cells. Treatments include medicines and bone marrow transplant.
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and ...
With unprecedented access to novel agents, lymphoma clinicians are now developing treatment plans such as CAR-T cell therapy and drug antibody conjugates.
... antibody). Signs of active herpes simplex type 1 or 2 or varicella within 4 ... Exposure to monoclonal antibodies, cytokines, growth factors, soluble ...
... monoclonal antibody therapy, amatuximab or any of its excipients); Pregnant and/or lactating females are excluded. A negative beta-human chorionic ...
... monoclonal antibody - Treatment with IV anti-cancer therapy =< 3 weeks prior to registration or with oral anti-cancer therapy =< 1 week prior to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.